SEC Filing Analysis: CervoMed Inc. (CRVO)

Executive Summary

• Trading Significance: Low
• Key Takeaway: A Director and 10% owner, who is also the spouse of the CEO, made several small open-market purchases, slightly increasing an already massive ownership stake to nearly 16% of the company.
• Market Impact: The transaction size is too small to directly impact the market, but the identity of the insider provides a strong qualitative signal of confidence.

Company Information

Field	Value
Company	CervoMed Inc.
Ticker Symbol	CRVO
CIK	0001053691
Industry	Pharmaceutical Preparations

Insider Information

Field	Value
Name	Gregoire Sylvie
CIK	0001335822
Title/Position	null
Relationship	Director, 10% Owner

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-11-13, 2025-11-14
Transaction Code	P (Open Market Purchase)
Security Type	Common Stock
Shares Involved	7,847 (total)
Price Per Share	~$7.53 (weighted average)
Total Value	$59,102.11
Shares Owned After	1,474,978
Ownership Type	Direct & Indirect

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$59,102.11
% of Market Cap	0.084%
Shares Transacted	7,847
% of Shares Outstanding	0.085%
Post-Transaction Ownership	1,474,978 shares (15.94% of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: The $59k transaction is negligible against CervoMed's $70 million market capitalization.
• Ownership Concentration: The key detail is the insider's post-transaction ownership of 15.94%, a highly concentrated position for an individual insider and their spouse (the CEO). This purchase, while small, reinforces their significant alignment with shareholders.
• Transaction Significance: Quantitatively, the transaction is rated 'Low' as it falls below the 0.1% thresholds for both market cap and shares outstanding. Qualitatively, a purchase by the CEO's family is a bullish signal, regardless of size.

Additional Context

Transaction Notes

• Special Circumstances: The filing reports three separate purchases across two days. The reporting person, Sylvie Gregoire, is a Director and the spouse of Dr. John Alam, the company's President & CEO. The shares are held jointly, in her own IRA, and in her spouse's IRA, indicating a coordinated family investment.